Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of SDW consult is 0.3% (very low). The 2025 annual accounts show equity of €336k and a net result of €61k. Equity is growing by ~42.5% per year across the filed fiscal years. Its solvency ranks better than 75% of 4723 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 5 annual accounts.
Signals
3 signals · with evidenceStrong solvency vs sector
Solvency is in the sector's strongest quartile: better than 75% of 4723 peers (2025). A comfortable equity buffer.
View the sector comparison Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
View the equity trend Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Filing behaviour
From the deposit records, complete market-wideLatest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 10-04-2026, 20 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 5 filed financial years, each closing on 30-09. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 30-09-2025, that is 30-04-2026.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 30-09-2025 | 30-04-2026 | 10-04-2026 | 20 d early | 2026-00081338 |
| 30-09-2024 | 30-04-2025 | 28-03-2025 | 33 d early | 2025-00060225 |
| 30-09-2023 | 30-04-2024 | 19-04-2024 | 11 d early | 2024-00067086 |
| 30-09-2022 | 30-04-2023 | 27-04-2023 | 3 d early | 2023-00067571 |
| 30-09-2021 | 30-04-2022 | 26-04-2022 | 4 d early | 2022-20010198 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsMore than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.3%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+Annual accounts: healthy financial profile
−
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€61k-36.6%
Working capital€230k+46.0%
Annual accounts & ratios
Source: NBB · 2025Annual accounts filed on 10-04-2026 with the NBB · fiscal year 2025 · micro
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~42.5%/year over 5 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 70, Head offices & management consulting · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 79.2% | 55.5% | |
| Net result | €61k | €38k | |
| Equity | €336k | €64k | |
| Gross operating margin | €98k | €61k | |
| Total assets | €424k | €146k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
P75
Improving position over 2021-2025
· n=3465-12464
P67
Stable position over 2021-2025
· n=3464-12466
P91
Improving position over 2021-2025
· n=3470-12472
P70
Improving position over 2021-2025
· n=3455-12452
Describes the position versus peers, not a forecast.
€97k
-33.2%
21-25
€61k
-36.6%
21-25
€86k
-27.6%
21-25
€424k
+12.3%
21-25
€336k
+22.2%
21-25
€230k
+46.0%
21-25
€16k
-40.5%
21-25
€88k
-14.5%
21-25
€25k
-13.7%
21-25
€63k
-14.8%
21-25
10.12
+58.3%
21-25
10.12
+58.3%
21-25
79.2%
+8.9%
21-25
0.26
-30.0%
21-25
18.2%
-48.1%
21-25
14.4%
-43.5%
21-25
96.50
-28.8%
21-25
Figures by fiscal year
| Fiscal year | 2025 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €97k |
| Net profit | €61k |
| Cash flow | €86k |
| Staff costs | - |
| Income taxes | €16k |
| Dividends | - |
| Total assets | €424k |
| Equity | €336k |
| Debt | €88k |
| of which ≤ 1y | €25k |
| of which > 1y | €63k |
| Working capital | €230k |
| Employees (FTE) | - |
Ratios (computed)
| 2025 | |
|---|---|
| Current ratio | 10.12 |
| Quick ratio | 10.12 |
| Working capital ratio | 54.3% |
| Solvency | 79.2% |
| Debt / equity | 0.26 |
| Long-term debt ratio | 0.19 |
| Interest coverage | 96.50 |
| Gross margin | - |
| Net margin | - |
| ROA | 14.4% |
| ROE | 18.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €424k |
| Fixed assets | 21/28 | €169k |
| Tangible fixed assets | 22/27 | €169k |
| Current assets | 29/58 | €256k |
| Amounts receivable within one year | 40/41 | €125k |
| Investments | 50/53 | €79k |
| Cash & bank | 54/58 | €51k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €424k |
| Equity | 10/15 | €336k |
| Contributions / capital | 10/11 | €5k |
| Reserves | 13 | €331k |
| Amounts payable | 17/49 | €88k |
| Amounts payable after one year | 17 | €63k |
| Amounts payable within one year | 42/48 | €25k |
| Trade debts payable within one year | 44 | €5k |
| Income statement | ||
| Gross operating margin | 9900 | €98k |
| Operating result | 9901 | €72k |
| Financial income | 75 | €6k |
| Financial charges | 65 | €1k |
| Result before taxes | 9903 | €77k |
| Income taxes | 67/77 | €16k |
| Net result for the period | 9904 | €61k |
| Result to be appropriated | 9905 | €61k |
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2025 · computed93
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Structure & network
Connections & network
1 connected companyGroup structure
Subsidiary · 1 location
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Locations & real estate
Establishment units
1 locationSDW consult
since 20212.316.124.824
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area1.1 ha
Buildings1
Building footprint4,977 m²
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44054A0485/00W000 | Flanders | 1.1 ha | 1 · 4,977 m² | - |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
1 acts All acts · 1
updated 2 months ago
2026
01-06-2026 General meeting · Officer reappointment · Permanent representative · Auditor mandate
- Filing: 2026-05-28 · GEEVO
- General meeting: 2026-03-31 · GEEVO
- Officer reappointment: role: bestuurder, end_date: 2032-03-31, start_date: 2026-04-01 · GEEVO
- Permanent representative: role: vaste vertegenwoordiger, start_date: 2026-04-01 · SDW consult
- Auditor mandate: role: commissaris, duration: drie boekjaren, fiscal_years: 2025-2026 tot 2027-2028, end_condition: algemene vergadering van het jaar 2029 · GEEVO
- Board meeting: 2026-04-23 · GEEVO
- Officer reappointment: role: gedelegeerd bestuurder, duration: zes jaar, start_date: 2026-04-23, end_condition: gewone algemene vergadering in het boekjaar waarin deze termijn verstrijkt · GEEVO
- Officer reappointment: role: gedelegeerd bestuurder, duration: zes jaar, start_date: 2026-04-23, end_condition: gewone algemene vergadering in het boekjaar waarin deze termijn verstrijkt · GEEVO
- Permanent representative: role: vaste vertegenwoordiger, start_date: 2026-04-23 · GEENA
- Approval: description: herbenoeming als vaste vertegenwoordiger van BV GEENA · GEEVO
- General meeting: 2026-04-23 · GEEVO
- Officer reappointment: role: niet-statutaire bestuurder, duration: zes jaar, start_date: 2026-04-23, end_condition: gewone algemene vergadering in het boekjaar waarin deze verstrijkt · GEEVO
- Officer reappointment: role: niet-statutaire bestuurder, duration: zes jaar, start_date: 2026-04-23, end_condition: gewone algemene vergadering in het boekjaar waarin deze verstrijkt · GEEVO
- Permanent representative: role: vaste vertegenwoordiger, start_date: 2026-04-23 · GEENA
- Approval: description: herbenoeming als vaste vertegenwoordiger van BV GEENA · GEEVO
- Power of attorney: scope: uitvoering en verwerking en publicatie van de beslissingen van deze vergadering, duration: onbepaalde tijd, revocation: tot aan de uitdrukkelijke herroeping, substitution: met recht van indeplaatsstelling · GEEVO
- Power of attorney: scope: publicatie van de beslissingen van deze vergadering · TITECA
- Publication: 2026-06-01
- Act object: ONTSLAGEN, BENOEMINGEN
Summary:
General meeting · Officer reappointment · Permanent representative · Auditor mandate
Analysis
Snowflake analysis
financial profile on 5 axes91
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
93
Profitability
91
Solvency
100
Growth
78
Stability
94
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soonAI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, ranked by comparable sizeCompany registry
Company registry (CBE)
Crossroads BankActivities
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220Verhuur en exploitatie van eigen of geleasd residentieel onroerend goed, exclusief sociale woningen68201Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen68201Administratieve en ondersteunende activiteiten ten behoeve van kantoren82100Diverse administratieve activiteiten ten behoeve van kantoren82110Overige zakelijke dienstverlening, n.e.g.82990Overige zakelijke dienstverlening, neg82990
Primary activity highlighted.
Names & trade names
| Legal nameNL | SDW consult |
Registered office
Gentsesteenweg 9
9800 Deinze, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.